Hims & Hers Health, Inc. (NYSE:HIMS) Receives $37.23 Consensus PT from Analysts

Hims & Hers Health, Inc. (NYSE:HIMS) has earned an average recommendation of “Hold” from the fifteen brokerages that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $37.23.

HIMS has been the topic of a number of recent research reports. BTIG Research initiated coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They set a “buy” rating and a $35.00 price target on the stock. Truist Financial boosted their price target on shares of Hims & Hers Health from $24.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. TD Cowen reiterated a “buy” rating and set a $28.00 price target on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Morgan Stanley lowered shares of Hims & Hers Health from an “overweight” rating to an “equal weight” rating and boosted their price target for the stock from $42.00 to $60.00 in a research note on Tuesday, February 18th. Finally, Needham & Company LLC boosted their price target on shares of Hims & Hers Health from $31.00 to $61.00 and gave the stock a “buy” rating in a research note on Tuesday, February 25th.

Hims & Hers Health Price Performance

NYSE HIMS opened at $36.01 on Friday. The firm’s 50-day moving average is $37.45 and its two-hundred day moving average is $27.31. Hims & Hers Health has a 12 month low of $11.20 and a 12 month high of $72.98. The stock has a market capitalization of $8.00 billion, a P/E ratio of 81.85 and a beta of 1.37.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The company had revenue of $481.14 million for the quarter, compared to analysts’ expectations of $494.56 million. As a group, analysts anticipate that Hims & Hers Health will post 0.29 EPS for the current year.

Insiders Place Their Bets

In other Hims & Hers Health news, insider Soleil Boughton sold 268,932 shares of the firm’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $27.75, for a total transaction of $7,462,863.00. Following the sale, the insider now owns 169,803 shares of the company’s stock, valued at approximately $4,712,033.25. This trade represents a 61.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael Chi sold 7,259 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $32.25, for a total transaction of $234,102.75. Following the sale, the insider now directly owns 184,947 shares in the company, valued at approximately $5,964,540.75. The trade was a 3.78 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,062,011 shares of company stock valued at $36,892,724. 17.71% of the stock is owned by corporate insiders.

Institutional Trading of Hims & Hers Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. IronOak Wealth LLC. acquired a new position in shares of Hims & Hers Health in the 4th quarter valued at $922,000. Kilter Group LLC acquired a new position in shares of Hims & Hers Health in the 4th quarter valued at $1,053,000. Cim LLC increased its holdings in shares of Hims & Hers Health by 1.0% in the 4th quarter. Cim LLC now owns 71,869 shares of the company’s stock valued at $1,738,000 after acquiring an additional 694 shares during the period. Jefferies Financial Group Inc. acquired a new position in shares of Hims & Hers Health in the 4th quarter valued at $4,900,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in shares of Hims & Hers Health in the 4th quarter valued at $200,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.